Catheter ablation of supraventricular tachycardia

Christopher Madias, Mark S. Link

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Supraventricular tachycardia (SVT) is not a universally agreed upon term. Patients with SVT can exhibit a variety of symptoms. The majority present with acute onset and termination of palpitations often described as a sensation of both fast and strong heartbeats. In general, it is important to obtain an electrocardiograms (ECG) recording at the time of symptoms. Although these tracings might not be diagnostic, they document the presence of SVT and can provide important clues as to the underlying cause of the arrhythmia. Once SVT has been documented, decisions regarding management with medications or catheter ablation can be discussed. Medical management might include atrioventricular (AV) nodal agents, such as beta blockers, calcium channel blockers and digoxin. Patient preparation includes withdrawal of AV nodal agents or antiarrhythmic medications for up to six doses and fasting after midnight. Focal atrial tachycardia (AT) is characterised as a SVT with centrifugal conduction that originates from a discrete location in either the left or right atrium.

Original languageEnglish (US)
Title of host publicationPractical Interventional Cardiology, Third edition
PublisherCRC Press
Pages535-550
Number of pages16
ISBN (Electronic)9781498735100
ISBN (Print)9781498735094
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Catheter ablation of supraventricular tachycardia'. Together they form a unique fingerprint.

Cite this